Cancer incidences in Europe related to mortalities, and ethnohistoric, genetic, and geographic distances

著者: Sokal, Robert R., Oden, Neal L., Rosenberg, Michael S., Thomson, Barbara A.
出版事項 2000

Ethnohistory, genetics, and cancer mortality in Europeans

著者: Sokal, Robert R., Oden, Neal L., Rosenberg, Michael S., DiGiovanni, Donna
出版事項 1997

Power of Automated Algorithms for Combining Time Line Follow Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials

著者: Oden, Neal L., VanVeldhuisen, Paul C., Wakim, Paul, Trivedi, Madhukar, Somoza, Eugene, Lewis, Daniel
出版事項 2011

SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients with Central Retinal Vein Occlusion

著者: Scott, Ingrid U., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Oden, Neal L., Figueroa, Maria
出版年 Am J Ophthalmol (2016)

SCORE Study Report 7: Incidence of Intravitreal Silicone Oil Droplets Associated With Staked-on Versus Luer Cone Syringe Design

著者: Scott, Ingrid U., Oden, Neal L., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Antoszyk, Andrew N.
出版事項 2009

SCORE2 Report 5: Vision-Related Function in Patients with Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

著者: Scott, Ingrid U., Figueroa, Maria J., Oden, Neal L., Ip, Michael S., Blodi, Barbara A., VanVeldhuisen, Paul C.
出版年 Am J Ophthalmol (2017)

SCORE Study Report 15: Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure after Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Reti...

著者: Aref, Ahmad A., Scott, Ingrid U., Oden, Neal L., Ip, Michael S., Blodi, Barbara A., VanVeldhuisen, Paul C.
出版年 JAMA Ophthalmol (2015)

Month 24 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Rep...

著者: Scott, Ingrid U., Oden, Neal L., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Chan, Clement K.
出版年 JAMA Ophthalmol (2019)

Association Between Early and Late Response in Eyes with Central or Hemiretinal Vein Occlusion Treated with Anti-VEGF Agents: SCORE2 Report 14: Secondary Analysis of the SCORE2 Cli...

著者: Khurana, Rahul N., Oden, Neal L., VanVeldhuisen, Paul C., Scott, Ingrid U., Blodi, Barbara A., Ip, Michael S.
出版年 Graefes Arch Clin Exp Ophthalmol (2021)

The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Optical Coherence Tomograms: SCORE Study Report 4

著者: Domalpally, Amitha, Blodi, Barbara A., Scott, Ingrid U., Ip, Michael S., Oden, Neal L., Lauer, Andreas K., VanVeldhuisen, Paul C.
出版事項 2009

SCORE Study Report 1: Baseline Associations between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion

著者: Scott, Ingrid U., VanVeldhuisen, Paul C., Oden, Neal L., Ip, Michael S., Blodi, Barbara A., Jumper, J. Michael, Figueroa, Maria
出版事項 2009

Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10

著者: Scott, Ingrid U., VanVeldhuisen, Paul C., Oden, Neal L., Ip, Michael S., Blodi, Barbara A., Hartnett, Mary Elizabeth, Cohen, Geoff
出版事項 2011

SCORE2 Report 2: Study Design and Baseline Characteristics

著者: Scott, Ingrid U., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Oden, Neal L., Figueroa, Maria, Dugel, Pravin U.
出版年 Ophthalmology (2016)

Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications: Secondary Outcomes Fr...

著者: Scott, Ingrid U., VanVeldhuisen, Paul C., Ip, Michael S., Blodi, Barbara A., Oden, Neal L., Altaweel, Michael, Berinstein, Daniel M.
出版年 JAMA Ophthalmol (2018)

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusio...

著者: Ip, Michael S., Oden, Neal L., Scott, Ingrid U., VanVeldhuisen, Paul C., Blodi, Barbara A., Ghuman, Thomas, Baker, Carl W.
出版年 JAMA Ophthalmol (2018)

SCORE Study Report 2: Interobserver Agreement Between Investigator and Reading Center Classification of Retinal Vein Occlusion Type

著者: Scott, Ingrid U., Blodi, Barbara A., Ip, Michael S., VanVeldhuisen, Paul C., Oden, Neal L., Chan, Clement K., MD, Victor Gonzalez
出版事項 2009

SCORE Study Report 3: Study Design and Baseline Characteristics

著者: Ip, Michael S., Oden, Neal L., Scott, Ingrid U., VanVeldhuisen, Paul C., Blodi, Barbara A., Figueroa, Maria, Antoszyk, Andrew, Elman, Michael
出版事項 2009

SCORE Study Report #11: Incidences of Neovascular Events in Eyes with Retinal Vein Occlusion

著者: Chan, Clement K., Ip, Michael S., VanVeldhuisen, Paul C., Oden, Neal L., Scott, Ingrid U., Tolentino, Michael J., Blodi, Barbara A.
出版事項 2011

Patient-Reported Visual Function Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned S...

著者: Scott, Ingrid U., VanVeldhuisen, Paul C., Barton, Franca, Oden, Neal L., Ip, Michael S., Blodi, Barbara A., Worrall, Martin, Fish, Gary E.
出版年 JAMA Ophthalmol (2019)

SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes with Central or Hemiretinal Vein Occlusion Managed with Aflibercept, Bevacizumab or Observation. Secondary Analysis of the...

著者: Hendrick, Andrew, VanVeldhuisen, Paul C., Scott, Ingrid U., King, Jacquie, Blodi, Barbara A., Ip, Michael S., Khurana, Rahul N., Oden, Neal L.
出版年 Am J Ophthalmol (2020)